机译:抗微生物管道是否具有成本效益? 对证据的叙述审查
National Institute for Health Research Health Protection Research Unit in Healthcare Associated;
National Institute for Health Research Health Protection Research Unit in Healthcare Associated;
Radboud University Medical Centre Radboud Institute for Health Sciences IQ Healthcare;
National Institute for Health Research Health Protection Research Unit in Healthcare Associated;
National Institute for Health Research Health Protection Research Unit in Healthcare Associated;
National Institute for Health Research Health Protection Research Unit in Healthcare Associated;
Antimicrobial resistance; Antimicrobial stewardship; Cost–benefit; Cost-effectiveness; Review;
机译:抗微生物管道是否具有成本效益? 对证据的叙述审查
机译:资源有限公司抗菌管理中临床微生物实验室的作用及挑战:叙事审查
机译:患有患者环境中的抗微生物管理干预的叙事综述和结果患者结果
机译:对人口的同伴审查文学的范围审查,对潜在的非抗微生物干预措施降低牛的抗微生物抗药性
机译:在线评论中的计算机介导说服力:统计和叙述证据。
机译:抗微生物管道计划;两部分叙述审查逐步设计和争议问题的问题I:迈出的设计抗微生物管道计划
机译:抗菌药物管理是否具有成本效益?对证据的叙述性审查